Slideshow

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

• You can skip this ad in 3 seconds.

• Slide

This slideshow reviews ceritinib (Zykadia), indicated for metastatic non-small cell lung cancer (NSCLC) in patients with ALK-positive tumors.